BICX Stock - BioCorRx Inc.
Unlock GoAI Insights for BICX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7,665 | $89,160 | $213,841 | $48,272 | $122,621 |
| Gross Profit | $5,998 | $53,174 | $198,562 | $42,391 | $26,673 |
| Gross Margin | 78.3% | 59.6% | 92.9% | 87.8% | 21.8% |
| Operating Income | $-5,122,505 | $-3,787,796 | $-2,908,499 | $-4,532,703 | $-3,027,347 |
| Net Income | $-5,106,124 | $-3,766,913 | $-4,369,413 | $-5,803,167 | $-4,014,989 |
| Net Margin | -66616.1% | -4224.9% | -2043.3% | -12021.8% | -3274.3% |
| EPS | $-0.49 | $-0.45 | $-0.61 | $-0.89 | $-0.75 |
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Visit WebsiteEarnings History & Surprises
BICXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | $-0.06 | — | — | — |
Q4 2025 | Nov 14, 2025 | $-0.06 | $-0.11 | -83.3% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | — | $-0.07 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.06 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.08 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.14 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.13 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.14 | — | — |
Q2 2024 | Apr 1, 2024 | — | $-0.11 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.10 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.11 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.12 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.15 | — | — |
Q4 2022 | Nov 15, 2022 | — | $-0.13 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.19 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.14 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.19 | — | — |
Q4 2021 | Nov 16, 2021 | — | $-0.21 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.16 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.26 | — | — |
Latest News
Frequently Asked Questions about BICX
What is BICX's current stock price?
What is the analyst price target for BICX?
What sector is BioCorRx Inc. in?
What is BICX's market cap?
Does BICX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BICX for comparison